Fig. 2From: Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancerProtein expression level of XRCC4 in several cancers and normal tissues. A Liver, B Breast, C Lung and (D) Kidney, × 100Back to article page